{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:01:49Z","timestamp":1780056109871,"version":"3.54.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015311","name":"Novartis Institutes for BioMedical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cocaine use disorder (CUD) is characterized by the continued use of cocaine despite serious impacts on life. This study focused on understanding the perspective of individuals with current CUD, individuals in CUD remission, and their supporters regarding current therapies, future therapies, and views on clinical trials for CUD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The online bulletin board (OBB) is a qualitative tool where participants engage in an interactive discussion on a virtual forum. Following completion of a screening questionnaire to determine eligibility, individuals in CUD remission and their supporters logged in to the OBB and responded to questions posed by the moderator. Individuals with current CUD participated in a one-time virtual focus group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All individuals with current CUD and 94% of those in CUD remission reported a diagnosis consistent with CUD or substance use disorder during screening. Individuals with current CUD and their supporters were recruited from the United States (US). Individuals in CUD remission were recruited from five countries, including the US. Individuals with current CUD reported hesitation about seeking treatment due to stigma, a lack of privacy, and being labeled as a drug seeker; barriers to therapy included time, cost, and a lack of privacy. Participants wanted a safe therapy to stop cravings and withdrawal symptoms. Seven clinical trial outcomes, including long-term abstinence and craving control, were suggested based on collected insights.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study can help inform the design of clinical trials and emphasize the need for effective, safe, and accessible therapies. Recruiting participants will require significant trust building.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2024.1230699","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T05:34:33Z","timestamp":1709184873000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient perspectives on current and potential therapies and clinical trial approaches for cocaine use disorder"],"prefix":"10.3389","volume":"15","author":[{"given":"Suzanne","family":"Maahs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Leclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Gomez-Mancilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Kiluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velusamy Shanmuganathan","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha S.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamashree","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Waye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"B1","volume-title":"World Drug Report 2021, Booklet 4 - Drug market trends: Cocaine, Amphetamine-type stimulants","year":"2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"Dsm-5 criteria for substance use disorders: Recommendations and rationale","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: A systematic analysis for the global burden of disease study 2016","volume":"5","author":"Alcohol","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/add.15242","article-title":"Pharmacotherapeutic strategies for treating cocaine use disorder-what do we have to offer","volume":"116","author":"Brandt","year":"2021","journal-title":"Addiction"},{"key":"B5","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2018","author":"Hedegaard","year":"2020","journal-title":"NCHS Data Brief"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303627","article-title":"Recent increases in cocaine-related overdose deaths and the role of opioids","volume":"107","author":"McCall Jones","year":"2017","journal-title":"Am J Public Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8049","article-title":"Comparison of treatments for cocaine use disorder among adults: A systematic review and meta-analysis","volume":"4","author":"Bentzley","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax1532","article-title":"The treatment of cocaine use disorder","volume":"5","author":"Kampman","year":"2019","journal-title":"Sci Adv"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.80","article-title":"Brain stimulation in ddiction","volume":"41","author":"Salling","year":"2016","journal-title":"Neuropsychopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"Am J Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874473711003010049","article-title":"Review of treatment for cocaine dependence","volume":"3","author":"Penberthy","year":"2010","journal-title":"Curr Drug Abuse Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011668","article-title":"Evaluation of the \"Pipeline\" for development of medications for cocaine use disorder: A review of translational preclinical, human laboratory, and clinical trial research","volume":"68","author":"Czoty","year":"2016","journal-title":"Pharmacol Rev"},{"key":"B13","article-title":"Opioid Use Disorder: Endpoints for demonstrating effectiveness of drugs for treatment guidance for industry","year":"2020"},{"key":"B14","volume-title":"Remarks from Fda Commissioner Scott Gottlieb, M.D., as Prepared for Oral Testimony before the House Committee on Energy and Commerce Hearing, \u201cFederal Efforts to Combat the Opioid Crisis: A Status Update on Cara and Other Initiatives","author":"Gottlieb","year":"2017"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.11.004","article-title":"Measures of outcome for stimulant trials: Acttion recommendations and research agenda","volume":"158","author":"Kiluk","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/add.14793","article-title":"Dropout rates of in-person psychosocial substance use disorder treatments: A systematic review and meta-analysis","volume":"115","author":"Lappan","year":"2020","journal-title":"Addiction"},{"key":"B17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5152\/addicta.2020.20055","article-title":"Feelings, thoughts and experiences of caregivers of individuals with substance use disorder","volume":"7","author":"Uluyol","year":"2020","journal-title":"ADDICTA: Turkish J Addict"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8934712","article-title":"Caregiver burden in alcohol dependence syndrome","volume":"2017","author":"Vaishnavi","year":"2017","journal-title":"J Addict"},{"key":"B19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/amh.Amh_6_18","article-title":"Caregiver burden in alcohol dependence syndrome in relation to the severity of dependence","volume":"19","author":"Swaroopachary","year":"2018","journal-title":"Arch Ment Health"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4103\/ijph.IJPH_396_16","article-title":"Caregiver burden on wives of substance-dependent husbands and its correlates at a tertiary care centre in Northern India","volume":"61","author":"Shekhawat","year":"2017","journal-title":"Indian J Public Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2010.489450","article-title":"Caregiver burden and alcohol use in a community sample","volume":"29","author":"Rospenda","year":"2010","journal-title":"J Addict Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4103\/ijsp.ijsp_117_19","article-title":"Brewing caregiver burden: Indian insights into alcohol use disorder","volume":"36","author":"Kadam","year":"2020","journal-title":"Indian J Soc Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-021-00344-3.25","article-title":"\"I can't live like that\": The experience of caregiver stress of caring for a relative with substance use disorder","volume":"16","author":"Maina","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"B24","article-title":"The burden of caring: Drug users & Their families","volume":"137","author":"Mannelli","year":"2013","journal-title":"Indian J Med Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0856-0","article-title":"Understanding patient preferences and unmet needs in non-alcoholic steatohepatitis (Nash): Insights from a qualitative online bulletin board study","volume":"36","author":"Cook","year":"2019","journal-title":"Adv Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12325-019-01134-x","article-title":"Gathering structured patient insight to drive the pro strategy in copd: Patient-centric drug development from theory to practice","volume":"37","author":"Patalano","year":"2020","journal-title":"Adv Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2196\/mental.4266","article-title":"An online, moderated peer-to-peer support bulletin board for depression: User-perceived advantages and disadvantages","volume":"2","author":"Griffiths","year":"2015","journal-title":"JMIR Ment Health"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-00900-1","article-title":"Patient needs, perceptions, and attitudinal drivers associated with obesity: A qualitative online bulletin board study","volume":"36","author":"Cook","year":"2019","journal-title":"Adv Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1037\/ccp0000447","article-title":"A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition","volume":"87","author":"Magill","year":"2019","journal-title":"J Consult Clin Psychol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4073\/csr.2017.2","article-title":"12-step programs for reducing illicit drug use","volume":"13","author":"B\u00f8g","year":"2017","journal-title":"Campbell Systematic Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2011.620425","article-title":"A randomized controlled trial comparing integrated cognitive behavioral therapy versus individual addiction counseling for co-occurring substance use and posttraumatic stress disorders","volume":"7","author":"McGovern","year":"2011","journal-title":"J Dual Diagn"},{"key":"B32","volume-title":"2015 National Survey on Drug Use and Health: Detailed Tables","year":"2016"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1230699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T05:34:41Z","timestamp":1709184881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1230699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":32,"alternative-id":["10.3389\/fpsyt.2024.1230699"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1230699","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"article-number":"1230699"}}